Cited by 3Gastrointestinal motility and disordersGastroesophageal reflux and treatmentsGastrointestinal Bleeding Diagnosis and Treatment

The DOI matches its Crossref record; its reference list is not available.

Short-term and Long-term Efficacy of Gastric Peroral Endoscopic Myotomy for Refractory Gastroparesis: A Meta-analysis

Khan, Shahryar, Shafiq, Muhammad, Khan, Mashal Alam, Ahmad, Aamer, Ehsan, Nimra, Ahmad, Nouman, Tripathi, Alok, Esfandyari, Tuba·2025·Journal of Clinical Gastroenterology

Abstract

Background Gastric peroral endoscopic myotomy (G-POEM) is an emerging endoscopic approach to treat refractory gastroparesis (GP). Previous studies have shown short-term benefits, but the long-term outcomes are unclear. This analysis evaluated the short- and long-term efficacy of G-POEM compared with standard medical treatment for adults with refractory GP. Methods We performed a systematic review and meta-analysis of studies that evaluated G-POEM for refractory GP. Clinical success was defined variably across studies, most commonly as a ≥50% reduction in Gastroparesis Cardinal Symptom Index (GCSI) scores or combined symptoms and gastric emptying improvement. Pooled estimates for clinical success, GCSI scores, and gastric emptying scintigraphy (GES) were calculated using a random effects model. Adverse events and predictors of long-term outcomes were assessed. Results This meta-analysis included 23 studies involving 871 patients who underwent G-POEM. The clinical response rates remained consistently above 70% during the first year, peaked at 79% at 24 months, and reached 81% at 60 months. G-POEM was associated with significant and durable reductions in GCSI scores at 1 month (SMD -2.68, 95% CI: -3.58 to -1.78), 12 months (SMD -2.12, 95% CI: -2.73 to -1.50), and 60 months (SMD -2.55, 95% CI: -4.88 to -0.23), as well as sustained improvements in gastric emptying at 12 months (SMD -33.60%, P Conclusions G-POEM may offer sustained symptoms and gastric emptying improvement in refra…

Overview

Integrity signals

Registry

Crossref · 10.1097/mcg.0000000000002279

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

No citation lists for this paper

No citation lists for this paper yet — checked again daily.

References 39 · Cited by 3

Research works printed but not linked: 37

  1. Schol, 2021, United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis, United European Gastroenterol J, 9, 287, 10.1002/ueg2.12060 · DOI
  2. Mekaroonkamol, 2022, A new paradigm shift in gastroparesis management, Gut Liver, 16, 825, 10.5009/gnl210309 · DOI
  3. Wadhwa, 2017, Healthcare utilization and costs associated with gastroparesis, World J Gastroenterol, 23, 4428, 10.3748/wjg.v23.i24.4428 · DOI
  4. Myint, 2018, Current and emerging therapeutic options for gastroparesis, Gastroenterol Hepatol (N Y), 14, 639
  5. McCurdy, 2023, Gastric peroral endoscopic pyloromyotomy (G-POEM) in patients with refractory gastroparesis: a review, Therap Adv Gastroenterol, 16, 17562848231151289, 10.1177/17562848231151289 · DOI
  6. Zhang, 2019, Gastric peroral endoscopic myotomy for gastroparesis: a systematic review of efficacy and safety, Gastroenterol Hepatol, 42, 413, 10.1016/j.gastrohep.2019.01.008 · DOI
  7. Mekaroonkamol, 2019, Gastric peroral endoscopic pyloromyotomy reduces symptoms, increases quality of life, and reduces health care use for patients with gastroparesis, Clin Gastroenterol Hepatol, 17, 82, 10.1016/j.cgh.2018.04.016 · DOI
  8. Abdelfatah, 2021, Long-term outcome of gastric per-oral endoscopic pyloromyotomy in treatment of gastroparesis, Clin Gastroenterol Hepatol, 19, 816, 10.1016/j.cgh.2020.05.039 · DOI
  9. Shen, 2020, Gastric peroral endoscopic pyloromyotomy versus gastric electrical stimulation in the treatment of refractory gastroparesis: a propensity score-matched analysis of long term outcomes, Endoscopy, 52, 349, 10.1055/a-1111-8566 · DOI
  10. Hernández Mondragón, 2022, Gastric peroral endoscopic myotomy outcomes after 4 years of follow-up in a large cohort of patients with refractory gastroparesis (with video), Gastrointest Endosc, 96, 487, 10.1016/j.gie.2022.03.025 · DOI
  11. Labonde, 2022, Gastric peroral endoscopic myotomy in refractory gastroparesis: long-term outcomes and predictive score to improve patient selection, Gastrointest Endosc, 96, 500, 10.1016/j.gie.2022.04.002 · DOI
  12. Gregor, 2021, Gastric peroral endoscopic myotomy for the treatment of refractory gastroparesis: a prospective single-center experience with mid-term follow-up (with video), Gastrointest Endosc, 94, 35, 10.1016/j.gie.2020.12.030 · DOI
  13. Xu, 2018, Gastric peroral endoscopic myotomy (G-POEM) as a treatment for refractory gastroparesis: long-term outcomes, Can J Gastroenterol Hepatol, 2018, 6409698, 10.1155/2018/6409698 · DOI
  14. Vosoughi, 2022, Gastric per-oral endoscopic myotomy (G-POEM) for refractory gastroparesis: results from an international prospective trial, Gut, 71, 25, 10.1136/gutjnl-2020-322756 · DOI · Paper page
  15. Ichkhanian, 2023, Gastric peroral endoscopic myotomy for management of refractory gastroparesis in patients with gastric neurostimulator devices: a multicenter retrospective case control study, Gastrointest Endosc, 98, 559, 10.1016/j.gie.2023.04.2079 · DOI
  16. Conchillo, 2021, Gastric peroral endoscopic pyloromyotomy for decompensated gastroparesis: comprehensive motility analysis in relation to treatment outcomes, Endosc Int Open, 9, E137, 10.1055/a-1311-0859 · DOI
  17. Gourcerol, 2023, Gastric electrical stimulation versus per-oral pyloromyotomy for the treatment of nausea and vomiting associated with gastroparesis: an observational study of two cohorts, Neurogastroenterol Motil, 35, e14565, 10.1111/nmo.14565 · DOI
  18. Dacha, 2017, Outcomes and quality-of-life assessment after gastric per-oral endoscopic pyloromyotomy (with video), Gastrointest Endosc, 86, 282, 10.1016/j.gie.2017.01.031 · DOI
  19. Chung, 2022, Efficacy and safety of gastric peroral endoscopic myotomy (G-POEM) for refractory gastroparesis: 3-year follow up results, J Formos Med Assoc, 121, 1334, 10.1016/j.jfma.2021.08.029 · DOI
  20. Reja, 2022, Gastric peroral endoscopic myotomy: a specific learning curve, J Clin Gastroenterol, 56, 339, 10.1097/MCG.0000000000001537 · DOI
  21. Husťak, 2020, Per-oral endoscopic pyloromyotomy (g-poem) for the treatment of gastroparesis - a pilot single-centre study with mid-term follow-up, Rozhl Chir, 99, 116, 10.33699/PIS.2020.99.3.116-123 · DOI
  22. Ragi, 2021, One-year results of gastric peroral endoscopic myotomy for refractory gastroparesis: a French multicenter study, Endoscopy, 53, 480, 10.1055/a-1205-5686 · DOI
  23. Kahaleh, 2018, Gastric peroral endoscopic myotomy for the treatment of refractory gastroparesis: a multicenter international experience, Endoscopy, 50, 1053, 10.1055/a-0596-7199 · DOI
  24. Gonzalez, 2017, G-POEM with antro-pyloromyotomy for the treatment of refractory gastroparesis: mid-term follow-up and factors predicting outcome, Aliment Pharmacol Ther, 46, 364, 10.1111/apt.14132 · DOI
  25. Khashab, 2017, Gastric per-oral endoscopic myotomy for refractory gastroparesis: results from the first multicenter study on endoscopic pyloromyotomy (with video), Gastrointest Endosc, 85, 123, 10.1016/j.gie.2016.06.048 · DOI
  26. Malik, 2018, Gastric per oral endoscopic myotomy (G-POEM) for the treatment of refractory gastroparesis: early experience, Dig Dis Sci, 63, 2405, 10.1007/s10620-018-4976-9 · DOI
  27. Tan, 2024, A long-term follow-up study of gastric peroral endoscopic myotomy (G-POEM) in a large cohort of patients with postsurgical gastroparesis, Surg Endosc, 38, 7416, 10.1007/s00464-024-11184-0 · DOI
  28. Azzolini, 2020, Gastric peroral endoscopic myotomy (G-POEM) for refractory gastroparesis: 3-month follow-up results, Dig Liver Dis, 52, 1215, 10.1016/j.dld.2020.07.023 · DOI
  29. Martinek, 2022, Endoscopic pyloromyotomy for the treatment of severe and refractory gastroparesis: a pilot, randomised, sham-controlled trial, Gut, 71, 2170, 10.1136/gutjnl-2022-326904 · DOI
  30. Aghaie Meybodi, 2019, Efficacy and feasibility of G-POEM in management of patients with refractory gastroparesis: a systematic review and meta-analysis, Endosc Int Open, 7, E322, 10.1055/a-0812-1458 · DOI
  31. Malik, 2025, Efficacy and safety of gastric peroral endoscopic myotomy across different etiologies of gastroparesis: systematic review and meta-analysis, Gastrointest Endosc, 101, 54, 10.1016/j.gie.2024.08.024 · DOI
  32. Canakis, 2023, Long-term outcomes (≥3 years) after gastric peroral endoscopic myotomy for refractory gastroparesis: a systematic review and meta-analysis, iGIE, 2, 344, 10.1016/j.igie.2023.07.007 · DOI
  33. Varghese, 2024, Predictors of outcomes after gastric peroral endoscopic myotomy for refractory gastroparesis: a systematic review, Am J Gastroenterol, 120, 1275, 10.14309/ajg.0000000000003213 · DOI
  34. Camilleri, 2022, ACG clinical guideline: gastroparesis, Am J Gastroenterol, 117, 1197, 10.14309/ajg.0000000000001874 · DOI · Paper page
  35. Wise, 2023, Response and adverse event rates with placebo in gastroparesis: a systematic review and meta-analysis, Clinical Gastroenterology and Hepatology, 21, 1447, 10.1016/j.cgh.2022.09.033 · DOI
  36. Chen, 2025, The American Neurogastroenterology and Motility Society Gastroparesis Cardinal Symptom Index-Daily Diary (ANMS GCSI-DD): psychometric validation and meaningful change threshold in patients with idiopathic or diabetic gastroparesis, Neurogastroenterol Motil, 37, e14960, 10.1111/nmo.14960 · DOI
  37. Pasricha, 2017, White Paper AGA: gastroparesis: clinical and regulatory insights for clinical trials, Clin Gastroenterol Hepatol, 15, 1184, 10.1016/j.cgh.2017.04.011 · DOI

Metadata

Authors
Khan, S., Shafiq, M., Khan, M. A., Ahmad, A., Ehsan, N., Ahmad, N., Tripathi, A., & Esfandyari, T.
Affiliations
  • University of Kansas Medical Center (US)
  • Khyber Medical University (PK)
Corresponding author
  • Khan, Shahryar
  • Shafiq, Muhammad
  • Tripathi, Alok
Venue
Journal of Clinical Gastroenterology
Published
2025-11-11
ISSN
  • 0192-0790 (ISSN-L)
  • 1539-2031
OpenAlex
W4416112182
Cited by
3
References
39
Citations by year
2026: 3
FWCI
2.87
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Clinical Gastroenterology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Health Sciences › Medicine › Gastroenterology › Gastroesophageal reflux and treatments
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal Bleeding Diagnosis and Treatment
Keywords
gastric peroral endoscopic myotomy, refractory gastroparesis, long-term efficacy, Gastroparesis Cardinal Symptom Index, gastric emptying, idiopathic gastroparesis, botulinum toxin injection, adverse events, symptom severity, disease duration, predictors of treatment response, predictors of treatment failure

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review